Clinical Trials Logo

Filter by:
NCT ID: NCT05813665 Not yet recruiting - Clinical trials for Giant Cell Tumor of Bone

A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone

Start date: April 2023
Phase: Phase 3
Study type: Interventional

This is a phase Ⅲ, multi-center, randomized, double-blind, active-controlled study to evaluate the efficacy and safety of narlumosbart (JMT103) in patients with unresectable or surgically difficult giant cell tumor of bone (GCTB). This clinical trial study hypothesizes narlumosbart administration groups are not inferior to active control administration groups.

NCT ID: NCT05810805 Not yet recruiting - Clinical trials for Inflammatory Bowel Diseases

Measurement and Analysis of Gas Composition in Digestive Tract

Start date: April 1, 2023
Phase:
Study type: Observational

The purpose of this study is to detect the concentration of various gases,including hydrogen, methane, hydrogen sulfide, nitric oxide in different parts of the digestive tract by a safe and direct method, and to establish a human digestive tract gas profiles. Analyze the differences in gas components in different segments of the digestive tract in patients with different diseases, and analyze the correlation between specific gases and digestive tract diseases and non-specific symptoms.

NCT ID: NCT05808894 Not yet recruiting - Clinical trials for Laparoscopic Pancreaticoduodenectomy

Extended Pancreatic Neck Transection Versus Conventional Pancreatic Neck Transection During Laparoscopic Pancreaticoduodenectomy( LPDEXCEPT)

LPDEXCEPT
Start date: August 2023
Phase: N/A
Study type: Interventional

The investigators conduct the clinical randomized controlled trial to evaluate the superiority of extended pancreatic neck transection during laparoscopic pancreaticoduodenectomy (LPD). The participants in the study group obtain extended pancreatic neck transection during LPD, while participants in the control group conventional pancreatic neck transection. The purposes of this study include: 1.Primary objective: To compare the incidence of clinically relevant pancreatic fistula (grades B-C according International Study Group on Pancreatic Surgery) between the study group and the control group. 2.Secondary objective: To compare the incidence of postoperative morbidity (Clavien-Dindo score ≥3)between the two groups. To compare the location of pancreatic duct and the surgical performance of pancreaticojejunostomy between the two groups.

NCT ID: NCT05808751 Not yet recruiting - Clinical trials for Cardiac Rehabilitation

Clinical Cardiac Rehabilitation Registry Study

Start date: July 1, 2023
Phase:
Study type: Observational [Patient Registry]

Establish an electronic cardiac rehabilitation patient registration system and clinical database, carry out prospective cohort follow-up and observation of cardiovascular disease (CVD) patients receiving cardiac rehabilitation in inpatients and outpatients, collect risk factors, diagnosis and treatment status, rehabilitation diagnosis and treatment, clinical outcomes and follow-up results, and establish a short-term and long-term follow-up mechanism.

NCT ID: NCT05808608 Not yet recruiting - Clinical trials for Renal Cell Carcinoma

A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma

Start date: September 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase Ib/II, open-label, single arm trial to evaluate the efficacy and safety of AK104 in combination with axitinib as a first-line treatment for advanced/metastatic special pathological subtypes of renal cell carcinoma (ssRCC). Subjects will receive AK104 plus axitinib until disease progression, development of unacceptable toxic effects, death, a decision by the physician or patient to withdraw from the trial. The primary endpoint is ORR and PFS per RECIST v1.1 and imRECIST as assessed by investigators.

NCT ID: NCT05807984 Not yet recruiting - Rectal Cancer Clinical Trials

Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion

Start date: May 1, 2023
Phase: Phase 2
Study type: Interventional

Prospective phase II clinical study aim to explore the clinical outcome of patients with unresectable locally recurrent rectal cancer (LRRC) treated with re-irradiation by carbon ion radiotherapy (CIRT)

NCT ID: NCT05807893 Not yet recruiting - Brain Metastases Clinical Trials

Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases

SUPER BRAIN
Start date: April 14, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

A multicenter, single-arm, open study to evaluate the safety and efficacy of Serplulimab in combination with bevacizumab and first-line chemotherapy in driver negative non-squamous NSCLC patients with brain metastases

NCT ID: NCT05806671 Not yet recruiting - Breast Cancer Clinical Trials

Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy

Start date: May 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if the triplet combination of dalpiciclib, fulvestrant, and pyrotinib is safe and effective in the treatment of hormone receptor-positive, HER2-low locally advanced/metastatic breast cancer following treatment with an aromatase inhibitor plus a CDK4/6 inhibitor (palbociclib abemaciclib or ribociclib). The study will employ a Bayesian Optimal Phase II (BOP2) design which explicitly controls the type I error rate, thereby bridging the gap between Bayesian designs and frequentist designs, and has favorable operating characteristics with higher power and lower risk of incorrectly terminating the trial than some existing Bayesian phase II designs.

NCT ID: NCT05806281 Not yet recruiting - Emotional Distress Clinical Trials

The Role of Cognitive Flexibility in Mindfulness Intervention for Emotional Distress

Start date: April 15, 2023
Phase: N/A
Study type: Interventional

This study hopes to: 1. explore whether offline and online mindfulness interventions can significantly alleviate individual emotional distress and improve cognitive flexibility level. 2. explore whether cognitive flexibility is a mediator in mindfulness intervention to alleviate emotional distress, and to meet the principles of mechanism.

NCT ID: NCT05805072 Not yet recruiting - Clinical trials for Relapsed/Refractory AML

Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of selinexor and HAAG +/- HMA in relapsed/refractory acute leukemia (AML) patients.